Calc Function

    • Calcs that help predict probability of a diseaseDiagnosis
    • Subcategory of 'Diagnosis' designed to be very sensitiveRule Out
    • Disease is diagnosed: prognosticate to guide treatmentPrognosis
    • Numerical inputs and outputsFormula
    • Med treatment and moreTreatment
    • Suggested protocolsAlgorithm

    Disease

    Select...

    Specialty

    Select...

    Chief Complaint

    Select...

    Organ System

    Select...

    Patent Pending

    FREGAT Trial (2019): Minimally Invasive Esophagectomy for Esophageal Cancer

    Visualmed

    FREGAT Trial

    Source: NEJM

    FREGAT Trial Key Points

    1. Minimally invasive esophagectomy (MIE) was found to have significantly lower complications and side effects compared to open esophagectomy.
    2. The 3 years survival rate was also higher among patients undergoing minimal invasive esophagectomy.
    3. Open esophagectomy is known to have significant morbidity ranging from 17.9% to 58%, with up to 6% mortality. Therefore, the minimally invasive hybrid procedure is now being utilized to limit the adverse events.